{
    "2020-05-18": [
        [
            {
                "time": "2020-06-15",
                "original_text": "We anticipate a U-Shaped to Swoosh-Shaped recovery: Strategist",
                "features": {
                    "keywords": [
                        "U-Shaped",
                        "Swoosh-Shaped",
                        "recovery"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "economy",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-11-16",
                "original_text": "Moderna COVID-19 vaccine data is ‘baby-step’ in right direction: Expert",
                "features": {
                    "keywords": [
                        "Moderna",
                        "COVID-19",
                        "vaccine",
                        "data",
                        "baby-step",
                        "right direction"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-08-12",
                "original_text": "Here’s what it will take for the stock market to hit a new record within 2 months",
                "features": {
                    "keywords": [
                        "stock market",
                        "record",
                        "months"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-11-16",
                "original_text": "Moderna Soars: Biotech ETFs in Focus",
                "features": {
                    "keywords": [
                        "Moderna",
                        "Soars",
                        "Biotech",
                        "ETFs"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-08-04",
                "original_text": "Pfizer Inc. -- Moody's assigns A1 to Pfizer's notes; on review for downgrade",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Moody's",
                        "A1",
                        "notes",
                        "review",
                        "downgrade"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-12-08",
                "original_text": "Sarepta Surges on Rival Pfizer's DMD Gene Therapy Study Data",
                "features": {
                    "keywords": [
                        "Sarepta",
                        "Surges",
                        "Rival",
                        "Pfizer",
                        "DMD",
                        "Gene Therapy",
                        "Study Data"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-07-20",
                "original_text": "Who Is Winning the COVID-19 Vaccine Race?",
                "features": {
                    "keywords": [
                        "Winning",
                        "COVID-19",
                        "Vaccine",
                        "Race"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-09-18",
                "original_text": "Pfizer Reports Efficacy & Safety Data on DMD Gene Therapy",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Reports",
                        "Efficacy",
                        "Safety",
                        "Data",
                        "DMD",
                        "Gene Therapy"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-03-18",
                "original_text": "Pfizer Just Began A Coronavirus Vaccine Test — Is PFE Stock A Buy?",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Coronavirus",
                        "Vaccine",
                        "Test",
                        "PFE",
                        "Stock",
                        "Buy"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-07-02",
                "original_text": "Glaxo-held firm ends HIV study early as injectable shows higher efficacy than daily pill",
                "features": {
                    "keywords": [
                        "Glaxo-held",
                        "firm",
                        "HIV",
                        "study",
                        "early",
                        "injectable",
                        "higher",
                        "efficacy",
                        "daily",
                        "pill"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}